BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

ZEISS Secures US FDA 510(k) Clearance for Cloud-Based CLINIC 360 Ophthalmic Platform

ZEISS Medical Technology, one of the world's leading medical technology companies, today announced the 510k clearance from the U.S. Food and Drug Administr...

August 21, 2026 | Regulatory

Singapore Launches First Biological Data Centre Prototype to Advance Energy-Efficient AI Computing

DayOne Data Centers Limited ("DayOne"), a Singapore-headquartered global digital infrastructure platform, today launched Singapore's first Biological Data ...

August 18, 2026 | News

Kyowa Kirin Taps Cognizant and Benchling to Build AI-Powered Drug Discovery Foundation in Japan

Cognizant announced that it will support the introduction and implementation of Benchling, the AI platform for R&D at Tokyo Research Park and Fuji Rese...

August 18, 2026 | News

Optellum, Coreline Soft Join Forces to Build Integrated AI Pathway for Lung Nodule Care

Proposed collaboration would make Coreline Soft's FDA-cleared lung nodule detection capability available through Optellum's LungOS® platform &nbs...

August 17, 2026 | News

The Technology Is Ready. Are APAC’s Regulators?

In a process-development suite in Singapore, or Hyderabad, or Songdo, a perfusion bioreactor can now run for weeks, its output feeding straight into a conn...

July 15, 2026 | Regulatory

Inductive Bio Brings AI-Powered ADMET Prediction Models to Claude via New MCP Connector

Inductive Bio, an AI drug discovery partner developing virtual chemistry labs, announced that it has joined Anthropic’s life sciences ecosystem and l...

July 02, 2026 | News

Can APAC Build Radioligand Therapy Before the Atoms Decay?

Every dose of radioligand therapy is a countdown. The moment a batch of lutetium-177 leaves the reactor, it begins to fade — roughly half its therape...

July 02, 2026 | Analysis

Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?

A new medicine arrives at a regulator's desk with two kinds of proof attached. The first is the familiar kind: a randomised controlled trial, blinded, cont...

June 30, 2026 | Analysis

Greenstone Biosciences And Intel Collaborate To Accelerate AI Driven Drug Discovery

Greenstone Biosciences, Inc. announces a collaboration with Intel Corp. (NASDAQ: INTC) to accelerate AI-enabled drug discovery usi...

June 22, 2026 | News

ZEISS And Envision Health Technologies Collaborate To Advance VR Based Glaucoma Testing

ZEISS Medical Technology and Envision Health Technologies will collaborate to advance the next generation of patient-accessible, software-driven visual fun...

June 22, 2026 | News

QIAGEN Bets Big on Digital PCR with Major QIAcuity Ecosystem Expansion

Planned gene expression assay launches and high-multiplex capabilities are expected to expand QIAcuity into one of the largest molecular biology applic...

June 16, 2026 | News

PromptBio Launches Agentic AI Platform to Accelerate Scientific Discovery

The PromptBio Platform combines conversational AI with multi-agent orchestration to accelerate discovery from hypotheses to insights PromptBio, a Californ...

June 11, 2026 | News

STARLIMS Completes Acquisition Of MODA® Platform From Lonza To Expand End To End Digital Manufacturing And Quality Capabilities

STARLIMS announced the successful completion of its acquisition of the MODA® Platform from Lonza, marking a major strategic expansion of its portfolio ...

May 07, 2026 | News

IHH Healthcare Selects Oracle Fusion Cloud To Unify Enterprise Systems And Advance AI Driven Care

Multinational integrated healthcare provider plans to consolidate multiple enterprise systems onto single AI-enabled cloud platform to boost productivity, ...

May 06, 2026 | News

Stay Connected